149 related articles for article (PubMed ID: 1531061)
1. Expression of interferon-gamma receptors in normal and psoriatic skin.
Scheynius A; Fransson J; Johansson C; Hammar H; Baker B; Fry L; Valdimarsson H
J Invest Dermatol; 1992 Feb; 98(2):255-8. PubMed ID: 1531061
[TBL] [Abstract][Full Text] [Related]
2. Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-alpha production in keratinocytes cultured from psoriatic lesions.
Nickoloff BJ; Mitra RS; Elder JT; Fisher GJ; Voorhees JJ
Br J Dermatol; 1989 Aug; 121(2):161-74. PubMed ID: 2476168
[TBL] [Abstract][Full Text] [Related]
3. Proliferation and interferon-gamma receptor expression in psoriatic and healthy keratinocytes are influenced by interactions between keratinocytes and fibroblasts in a skin equivalent model.
Fransson J; Emilson A; Scheynius A; Hammar H
Arch Dermatol Res; 1995; 287(6):517-23. PubMed ID: 7487135
[TBL] [Abstract][Full Text] [Related]
4. An altered response by psoriatic keratinocytes to gamma interferon.
Baker BS; Powles AV; Valdimarsson H; Fry L
Scand J Immunol; 1988 Dec; 28(6):735-40. PubMed ID: 3148190
[TBL] [Abstract][Full Text] [Related]
5. The effect of IFN-gamma on healthy and psoriatic keratinocytes in a skin equivalent model is influenced by the source of the keratinocytes and by their interactions with fibroblasts.
Fransson J; Shen Q; Scheynius A; Hammar H
Arch Dermatol Res; 1996 Dec; 289(1):14-20. PubMed ID: 9017130
[TBL] [Abstract][Full Text] [Related]
6. Distribution of interferon-gamma receptors in normal and psoriatic skin.
van den Oord JJ; De Ley M; De Wolf-Peeters C
Pathol Res Pract; 1995 Jul; 191(6):530-4. PubMed ID: 7479374
[TBL] [Abstract][Full Text] [Related]
7. Regulation of involucrin in psoriatic epidermal keratinocytes: the roles of ERK1/2 and GSK-3β.
Chen JQ; Man XY; Li W; Zhou J; Landeck L; Cai SQ; Zheng M
Cell Biochem Biophys; 2013 Jul; 66(3):523-8. PubMed ID: 23283814
[TBL] [Abstract][Full Text] [Related]
8. Immunohistopathologic studies in the development of psoriatic lesion influenced by gamma-interferon and the producing cells.
Kaneko F; Suzuki M; Takiguchi Y; Itoh N; Minagawa T
J Dermatol Sci; 1990 Nov; 1(6):425-34. PubMed ID: 2126953
[TBL] [Abstract][Full Text] [Related]
9. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
[TBL] [Abstract][Full Text] [Related]
11. Psoriatic keratinocytes show reduced IRF-1 and STAT-1alpha activation in response to gamma-IFN.
Jackson M; Howie SE; Weller R; Sabin E; Hunter JA; McKenzie RC
FASEB J; 1999 Mar; 13(3):495-502. PubMed ID: 10064616
[TBL] [Abstract][Full Text] [Related]
12. Keratinocyte CDw60 expression is modulated by both a Th-1 type cytokine IFN-gamma and Th-2 cytokines IL-4 and IL-13: relevance to psoriasis.
Huang BB; Bonish BK; Chaturvedi V; Qin JZ; Nickoloff BJ
J Invest Dermatol; 2001 Feb; 116(2):305-12. PubMed ID: 11180008
[TBL] [Abstract][Full Text] [Related]
13. IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production.
Wei L; Debets R; Hegmans JJ; Benner R; Prens EP
J Pathol; 1999 Feb; 187(3):358-64. PubMed ID: 10398092
[TBL] [Abstract][Full Text] [Related]
14. Response of keratinocytes from normal and psoriatic epidermis to interferon-gamma differs in the expression of zinc-alpha(2)-glycoprotein and cathepsin D.
Chen SH; Arany I; Apisarnthanarax N; Rajaraman S; Tyring SK; Horikoshi T; Brysk H; Brysk MM
FASEB J; 2000 Mar; 14(3):565-71. PubMed ID: 10698972
[TBL] [Abstract][Full Text] [Related]
15. Expression of 1,25-dihydroxyvitamin D3 receptors in normal and psoriatic skin.
Milde P; Hauser U; Simon T; Mall G; Ernst V; Haussler MR; Frosch P; Rauterberg EW
J Invest Dermatol; 1991 Aug; 97(2):230-9. PubMed ID: 1649228
[TBL] [Abstract][Full Text] [Related]
16. In situ localization of interferons in psoriatic lesions.
Livden JK; Nilsen R; Bjerke JR; Matre R
Arch Dermatol Res; 1989; 281(6):392-7. PubMed ID: 2480752
[TBL] [Abstract][Full Text] [Related]
17. Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets.
Szabo SK; Hammerberg C; Yoshida Y; Bata-Csorgo Z; Cooper KD
J Invest Dermatol; 1998 Dec; 111(6):1072-8. PubMed ID: 9856819
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells.
Bonish B; Jullien D; Dutronc Y; Huang BB; Modlin R; Spada FM; Porcelli SA; Nickoloff BJ
J Immunol; 2000 Oct; 165(7):4076-85. PubMed ID: 11034419
[TBL] [Abstract][Full Text] [Related]
19. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol).
Fukuoka M; Ogino Y; Sato H; Ohta T; Komoriya K; Nishioka K; Katayama I
Br J Dermatol; 1998 Jan; 138(1):63-70. PubMed ID: 9536224
[TBL] [Abstract][Full Text] [Related]
20. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM
J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
